Skip to main content

Applications of FDG PET in Oncology

Best Clinical Practice

  • Book
  • © 2021

Overview

  • Describes the use of FDG PET in a wide range of cancers
  • Explains how FDG PET plays a key role in evaluating the effects of new anticancer agents
  • Contains a wealth of informative images
  • 3372 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (9 chapters)

Keywords

About this book

This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management.

The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.



Reviews

“The book provides a detailed and insightful perspective … . It would make an interesting read for the inquisitive PETCT scholar, and it would be an invalu­able tool for the reader who is inter­ested in comparing PETCT practices across various jurisdictions.” (Wai Lup Wong, RAD Magazine, January, 2023)

Editors and Affiliations

  • Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan

    Hirofumi Fujii

  • Department of Respiratory Medicine, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan

    Hiroyuki Nakamura

  • Chairman of the board of trustee, Yotsuya Medical Cube, Tokyo, Japan

    Seiei Yasuda

About the editors

Hirofumi Fujii、M.D., Ph.D.
Division of Functional Imaging
Exploratory Oncology Research and Clinical Trial Center
National Cancer Center
Kashiwa, Japan

Professor Hiroyuki Nakamura, M.D., Ph.D.
Department of Respiratory Medicine
Tokyo Medical University Ibaraki Medical Center
Ibaraki, Japan

Seiei Yasuda, M.D., Ph.D.
Chairman of the board of trustee
Yotsuya Medical Cube
Tokyo, Japan

Bibliographic Information

  • Book Title: Applications of FDG PET in Oncology

  • Book Subtitle: Best Clinical Practice

  • Editors: Hirofumi Fujii, Hiroyuki Nakamura, Seiei Yasuda

  • DOI: https://doi.org/10.1007/978-981-15-8423-7

  • Publisher: Springer Singapore

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Singapore Pte Ltd. 2021

  • Hardcover ISBN: 978-981-15-8422-0Published: 08 December 2020

  • Softcover ISBN: 978-981-15-8425-1Published: 09 December 2021

  • eBook ISBN: 978-981-15-8423-7Published: 07 December 2020

  • Edition Number: 1

  • Number of Pages: VII, 147

  • Number of Illustrations: 6 b/w illustrations, 55 illustrations in colour

  • Topics: Oncology, Imaging / Radiology, Cancer Research

Publish with us